Plasma metabolomic profiles associated with cardiovascular disease in type 2 diabetes from the Trans-Omics for Precision Medicine (TOPMed) program

By afschroeder • May 6, 2026

Zhang Y, Nguyen NQH, Hanson PA, Sevilla-Gonzalez M, Haessler J, Sarnowski C, Yao J, Yu B, Jamshidi A, Boerwinkle E, Brown MR, Chen ZZ, Ida Chen YD, Clish C, DiCorpo D, Durda P, Gerszten R, Goodarzi MO, Guo X, Heard-Costa NL, Johnson WC, Kooperberg C, Pankow JS, Post WS, Reiner AP, Rich SS, Rotter JI, de Vries PS, Wood AC, Taylor KD, Manning AK, Dupuis J, Meigs JB, Liu CT. Plasma metabolomic profiles associated with cardiovascular disease in type 2 diabetes from the Trans-Omics for Precision Medicine (TOPMed) program. Atherosclerosis. 2026 Apr 26;417:120758. doi: 10.1016/j.atherosclerosis.2026.120758. Epub ahead of print. PMID: 42085744.

Tags: Biomarker identification, cardiovascular disease, Cedars Sinai DoM, Endocrinology, Plasma metabolomics, Publications, Type 2 diabetes

Integrated Strain-Flow Analysis for Early Assessment of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension

Hashemi MS, Falahatpisheh A, Farsiani Y, Matusov Y, Singh S, Ghafourian K, Pedrizzetti G, Kheradvar A. Integrated Strain-Flow Analysis for Early Assessment of Right Ventricular[...]

The Equivalents Are Coming! Developing a Shared Nomenclature for Radiopharmaceutical Therapy of Neuroendocrine Tumors, Prostate Cancer, and Beyond

Chauhan A, Hendifar AE, El-Haddad G, Soares HP, Herrmann K. The Equivalents Are Coming! Developing a Shared Nomenclature for Radiopharmaceutical Therapy of Neuroendocrine Tumors, Prostate[...]

A 20-minute, free-running, whole-heart cardiac MRI to image myocardial injury following reperfused myocardial infarction: demonstration in a large animal model

Zhang X, Yang HJ, Huang Y, Yoosefian G, Vora K, Youssef K, Wilk B, Christodoulou AG, Li D, Sharif B, Prato FS, Kumar A, Dharmakumar[...]